Literature DB >> 10652501

Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome.

H Krude1, A Grüters.   

Abstract

The recent discovery of the contribution of proopiomelanocortin (POMC)-derived peptides to the regulation of energy homeostasis and exocrine gland secretion in mice aroused new interest in the complex function of the endocrine POMC network. In addition, the first mutations in the gene encoding POMC have been identified in two patients affected by adrenal insufficiency, early onset severe obesity and red hair pigmentation. Therefore, the focus of this brief review will be the detailed discussion of the implications of these new findings in the physiology of the human POMC ligand-receptor system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652501     DOI: 10.1016/s1043-2760(99)00213-1

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  21 in total

Review 1.  From obesity genetics to the future of personalized obesity therapy.

Authors:  Julia S El-Sayed Moustafa; Philippe Froguel
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

Review 2.  Appetite responses to high-fat meals or diets of varying fatty acid composition: a comprehensive review.

Authors:  S Kaviani; J A Cooper
Journal:  Eur J Clin Nutr       Date:  2017-01-18       Impact factor: 4.016

Review 3.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

4.  Fluoxetine Modulates the Activity of Hypothalamic POMC Neurons via mTOR Signaling.

Authors:  Ilaria Barone; Riccardo Melani; Marco Mainardi; Gaia Scabia; Manuela Scali; Alessia Dattilo; Giovanni Ceccarini; Paolo Vitti; Ferruccio Santini; Lamberto Maffei; Tommaso Pizzorusso; Margherita Maffei
Journal:  Mol Neurobiol       Date:  2018-04-16       Impact factor: 5.590

5.  Circadian rise in maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal insufficiency.

Authors:  M Venihaki; A Carrigan; P Dikkes; J A Majzoub
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 6.  Melanocortin-3 receptors and metabolic homeostasis.

Authors:  Karima Begriche; Clemencé Girardet; Patricia McDonald; Andrew A Butler
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 7.  In search of adrenocortical stem and progenitor cells.

Authors:  Alex C Kim; Ferdous M Barlaskar; Joanne H Heaton; Tobias Else; Victoria R Kelly; Kenneth T Krill; Joshua O Scheys; Derek P Simon; Alessia Trovato; Wei-Hsiung Yang; Gary D Hammer
Journal:  Endocr Rev       Date:  2009-04-29       Impact factor: 19.871

8.  Human pituitary contains dual cathepsin L and prohormone convertase processing pathway components involved in converting POMC into the peptide hormones ACTH, alpha-MSH, and beta-endorphin.

Authors:  Vivian Hook; Lydiane Funkelstein; Thomas Toneff; Charles Mosier; Shin-Rong Hwang
Journal:  Endocrine       Date:  2009-04-03       Impact factor: 3.633

9.  Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse.

Authors:  Carrie Haskell-Luevano; Jay W Schaub; Amy Andreasen; Kim R Haskell; Marcus C Moore; Lorraine M Koerper; Francois Rouzaud; Henry V Baker; William J Millard; Glenn Walter; S A Litherland; Zhimin Xiang
Journal:  FASEB J       Date:  2008-10-29       Impact factor: 5.191

10.  Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency.

Authors:  Anne-Marie Pulichino; Sophie Vallette-Kasic; Catherine Couture; Yves Gauthier; Thierry Brue; Michel David; Georges Malpuech; Cheri Deal; Guy Van Vliet; Monique De Vroede; Felix G Riepe; Carl-Joachim Partsch; Wolfgang G Sippell; Merih Berberoglu; Begüm Atasay; Jacques Drouin
Journal:  Genes Dev       Date:  2003-03-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.